Abiopharma

🔍 Robbins Edward Hutchinson Jr. (Executive)

Company: TELOS CORP (TLS)

Report Date: 2026-03-17

Detailed Transactions and Holdings:

• Sold 37,096 shares of Common Stock at $4.01 per share (Direct)
  Date: 2026-03-17 | Code: S | equity_swap_involved: 0 | shares_owned_after: 631,805.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 64,527 shares of Common Stock at $4.02 per share (Direct)
  Date: 2026-03-18 | Code: S | equity_swap_involved: 0 | shares_owned_after: 567,278.00 | transaction_form_type: 4 | Footnotes: F2
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-03-17 | Code: H | nature_of_ownership: By 401k plan | shares_owned_after: 15,904.64

Footnotes:

• F1: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.00 to $4.05, inclusive. The reporting person undertakes to provide Telos Corporation, any security holder of Telos Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in these footnotes.
• F2: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.00 to $4.06, inclusive. The reporting person undertakes to provide Telos Corporation, any security holder of Telos Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in these footnotes.